Abstract
Hereditary leiomyomatosis and renal cell cancer is a hereditary cancer syndrome in which affected individuals are at risk for cutaneous and uterine leiomyomas, and renal cancer. Previous reports have stressed the aggressiveness of the renal tumours, often with early metastasis, despite small primary tumour size. Almost all the previously reported patients were adults, and different studies showed variability in penetrance for the renal tumours. We report a patient in whom renal cancer was detected at the age of 11 years at his first routine screening imaging after he was found to carry a fumarate hydratase gene mutation (c.1189G > A) transmitted from his mother. This report serves to emphasize the need to improve guidelines for screening of at risk individuals, including the necessity for predictive genetic testing and early institution of tumour surveillance in childhood.
Similar content being viewed by others
Abbreviations
- CT:
-
Computerized tomography
- FH:
-
Fumarate hydratase
- HLRCC:
-
Hereditary leiomyomatosis and renal cell carcinoma
- MRI:
-
Magnetic resonance image
- RCC:
-
Renal cell carcinoma
- VHL:
-
Von Hippel Lindau disease
References
Launonen V, Vierimaa O, Kiuru M et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387–3392
Alam NA, Bevan S, Churchman M et al (2001) Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3–q43. Am J Hum Genet 68:1264–1269
Tomlinson IP, Alam NA, Rowan AJ et al (2003) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410
Bayley JP, Launonen V, Tomlinson IP (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20
Toro JR, Nickerson ML, Wei MH et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106
Alam NA, Olpin S, Leigh IM (2005) Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153:11–17
Wei MH, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18–27
Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133
Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumours in hereditary leiomyomatosis and renal cell cancer syndrome. Am J Surg Pathol 31:1578–1585
Refae MA, Wong N, Patenaude F et al (2007) Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256–261
Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12(11):1241–1252
Badeloe S, Van Spaendonck-Zwarts KY, Van Steensel MA et al (2009) Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 160(3):707–709
Lehtonen HJ, Kiuru M, Ylisaukko-oja SK et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523–526
Johnston LB, Chew SL, Trainer PJ et al (2000) Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol 52(2):127–136
Acknowledgments
The authors are grateful to the family for permission to publish this information.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alrashdi, I., Levine, S., Paterson, J. et al. Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient. Familial Cancer 9, 239–243 (2010). https://doi.org/10.1007/s10689-009-9306-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-009-9306-0